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E-mail: franz.allerberger@ages.at“We are in the middle of a paradigm shift in bacterial infectious
diseases” [1]. This statement, by Didier Raoult, emphasizes the
role of individual clones in bacterial epidemics. It also unre-
strictedly holds true for the role of microbiological laboratory
diagnostics in community-acquired gastroenteritis today. An
episode of diarrhoea is never pleasant. Usually it is of short
duration— lasting just a few days—with infection the major
cause. However, the high numbers of potential enteric patho-
gens, coupled with the availability of new rapid detection
techniques, presently coerce microbiology laboratory users to
review protocols for ordering tests and analyses in order to
improve efﬁciency and timeliness of infectious diarrhoea
diagnoses.
The width of the spectrum of possible enteric pathogens is
impressively underlined by the results of a study published in
this issue [2]. Under the auspices of the ESCMID Food- and
Water-borne Infections Study Group (EFWISG), Spina et al.
performed a European multicentre, cross-sectional quarterly
point prevalence study on community-acquired diarrhoea.
The aim was to determine the range of possible pathogens in
acute community-acquired gastroenteritis using both con-
ventional laboratory techniques and a commercially available
multiplex PCR-based system. A high proportion of specimens
positive for multiple organisms (“mixed infections”)
were detected. Enteropathogenic Escherichia coli and/
or enteroaggregative E. coli were present in 84% of samples
with multiple organisms, which—according to Spina
et al.—raises the question of the true clinical relevance of
these pathogens.
In this issue of CMI, Hu and Torres also discuss the topic
“Enteropathogenic Escherichia coli: Foe or Innocent Bystander?”
and conclude that typical EPEC are found to be stronglyClinical Microbiology and Infection © 2015 European Society of Cassociated with cases of diarrhoea [3]. However, occurrence of
so-called atypical EPEC in hosts with or without diarrhoea fuels
the question of the role of these pathogens in human disease, a
question that—according to Hu and Torres—cannot be
answered by current epidemiologic data. As Martin J. Blaser
recently phrased it: “It’s tempting to think of pathogens as
intrinsically evil, but they’re not” [4].
Finally, prevention of illness is always superior to, or at
least more desirable than, treatment of illness. In their review,
“Rotavirus Vaccines: A Story of Success,” Kollaritsch et al.
underline the potential of vaccination in preventing
community-acquired diarrhoea [5]. After implementing rota-
virus vaccines in childhood immunization programs, rotavirus
hospitalizations were observed to be reduced more than 90%
in many settings in both the industrialized and resource-
deprived world.
One of the dilemmas in assessing patients with acute diar-
rhoea is deciding when to initiate antimicrobial therapy. The
role of antibiotics in the therapy of acute gastroenteritis is
summarized by Zollner-Schwetz and Krause in another review
published in this issue [6].
Routine diagnostic laboratories always struggle to improve
their diagnostic repertoire. To our chagrin, this endeavor is
probably endless. Yet many types of solutions are already
available. Multiplex screening can optimize the yield from
stool examinations, can dramatically improve timeliness of
diagnosis and can facilitate comparability of results among
different laboratories. I envisage that in the near future,
conventional laboratory methods directed at isolating speciﬁc
pathogens will become second-line tools, to be deployed only
when multiplex screening deems it necessary. The time has
come for us to begin implementing these syndromic tests in
our daily routine.
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